U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571525) titled 'Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis' on April 22.
Brief Summary: The goal of this observational study is to investigate the clinical, immunological, and neuromuscular features associated with the development and progression of myasthenia gravis (MG) in adult patients with thymic abnormalities and/or MG-related antibodies, including individuals with or without clinically manifest disease.
The main questions it aims to answer are:
* Whether integrated clinical, serological, and histopathological profiles are associated with the presence of MG and can predict disease onset or progress...